Affordable Access

deepdyve-link
Publisher Website

Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.

Authors
  • Berry, Jesse L1
  • Bechtold, Mercy2
  • Shah, Sona2
  • Zolfaghari, Emily3
  • Reid, Mark3
  • Jubran, Rima4
  • Kim, Jonathan W2
  • 1 USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California. Electronic address: [email protected]
  • 2 USC Roski Eye Institute, Keck School of Medicine of the University of Southern California, Los Angeles, California; The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • 3 The Vision Center at Children's Hospital Los Angeles, Los Angeles, California.
  • 4 The Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles, Los Angeles, California.
Type
Published Article
Journal
Ophthalmology
Publication Date
Dec 01, 2017
Volume
124
Issue
12
Pages
1817–1825
Identifiers
DOI: 10.1016/j.ophtha.2017.05.034
PMID: 28655537
Source
Medline
License
Unknown

Abstract

IVM is an effective treatment for vitreous seeding after intravenous chemotherapy for retinoblastoma. As with eyes treated with intra-arterial chemotherapy, seed classification is predictive of the total number and dose of IVM injections in eyes treated with intravenous chemotherapy. Eyes with clouds required significantly more injections than eyes with dust or spheres.

Report this publication

Statistics

Seen <100 times